Zimmer Biomet Holdings (ZBH) Payables (2009 - 2026)

Zimmer Biomet Holdings' Payables history runs 18 years deep, the most recent figure standing at $361.2 million for Q1 2026.

• On a quarterly basis, Payables rose 19.88% year-over-year to $361.2 million in Q1 2026; TTM through Mar 2026 was $361.2 million, a 19.88% increase from a year earlier, with the FY2025 full-year figure at $303.0 million, up 55.7% from the prior year.
• Payables climbed to $361.2 million in Q1 2026 per ZBH's latest filing, from $303.0 million in the prior quarter.
• Across five years, Payables topped out at $437.1 million in Q4 2022 and bottomed at $194.6 million in Q4 2024.
• The 5-year median for Payables is $333.9 million (2022), against an average of $337.7 million.
• Across the five-year window, Payables plunged 52.61% in 2024 and surged 55.7% in 2025, its largest moves.
• Year by year, Payables stood at $437.1 million in 2022, then dropped by 6.06% to $410.6 million in 2023, then plunged by 52.61% to $194.6 million in 2024, then soared by 55.7% to $303.0 million in 2025, then increased by 19.21% to $361.2 million in 2026.
• Per Business Quant, the three latest ZBH Payables figures stand at $361.2 million (Q1 2026), $303.0 million (Q4 2025), and $315.3 million (Q3 2025).